Literature DB >> 25414730

NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.

John N Barry1, Alexey A Vertegel2.   

Abstract

There has been a significant amount of research done on liposomes and nanoparticles as drug carriers for protein drugs. Proteins and enzymes have been used both as targeting moieties and for their therapeutic potential. High specificity and rapid reaction rates make proteins and enzymes excellent candidates for therapeutic treatment, but some limitations exist. Many of these limitations can be addressed by a well studied nanotechnology based delivery system. Such a system can provide a medium for delivery, stabilization of the drugs, and enable site specific accumulation of drugs. Nanomedicines such as these have great potential to revolutionize the pharmaceutical industry and improve healthcare worldwide.

Entities:  

Keywords:  Protein therapeutics; drug delivery; liposomes; nanomaterials; nanoparticles

Year:  2013        PMID: 25414730      PMCID: PMC4235794          DOI: 10.1142/S1793984413430010

Source DB:  PubMed          Journal:  Nano Life        ISSN: 1793-9844


  132 in total

Review 1.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

Authors:  Thomas Merdan; Jindrich Kopecek; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

Review 2.  Targeting of superoxide dismutase and catalase to vascular endothelium.

Authors:  V R Muzykantov
Journal:  J Control Release       Date:  2001-03-12       Impact factor: 9.776

3.  Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.

Authors:  Nuhad K Ibrahim; Brian Samuels; Ray Page; Dinesh Doval; Kirtikumar M Patel; S C Rao; Madhavan Krishnan Nair; Paul Bhar; Neil Desai; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

4.  The effect of liposomes with superoxide dismutase on A2182 cells.

Authors:  Ruzica Galović Rengel; Jelena Filipović-Grcić; Ivana Cepelak; Tihana Zanić-Grubisić; Karmela Barisić
Journal:  Eur J Pharm Biopharm       Date:  2005-01-18       Impact factor: 5.571

5.  Biological characterization of L-asparaginase liposomal formulations.

Authors:  M M Gaspar; R Perez-Soler; M E Cruz
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

6.  Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Authors:  Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

7.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

Review 8.  Protein nanoparticles as drug carriers in clinical medicine.

Authors:  Michael J Hawkins; Patrick Soon-Shiong; Neil Desai
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

9.  Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.

Authors:  V D Awasthi; D Garcia; R Klipper; B A Goins; W T Phillips
Journal:  J Pharmacol Exp Ther       Date:  2004-01-12       Impact factor: 4.030

10.  Glucose-sensitive liposomes incorporating hydrophobically modified glucose oxidase.

Authors:  Seong-Min Jo; Hyeon Yong Lee; Jin-Chul Kim
Journal:  Lipids       Date:  2008-08-27       Impact factor: 1.880

View more
  4 in total

1.  Catalase-Functionalized Iron Oxide Nanoparticles Reverse Hypoxia-Induced Chemotherapeutic Resistance.

Authors:  Tin-Yo Yen; Zachary R Stephen; Guanyou Lin; Qingxin Mu; Mike Jeon; Stela Untoro; Parker Welsh; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2019-09-26       Impact factor: 9.933

Review 2.  Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.

Authors:  Ravi Salgia; Mohit Kumar Jolly; Tanya Dorff; Clayton Lau; Keith Weninger; John Orban; Prakash Kulkarni
Journal:  J Clin Med       Date:  2018-06-17       Impact factor: 4.241

3.  Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules.

Authors:  Agnieszka Pudlarz; Janusz Szemraj
Journal:  Open Life Sci       Date:  2018-10-31       Impact factor: 0.938

4.  Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.

Authors:  A Griveau; H Alnemeh-Al Ali; M A Jourdain; A Dupont; J Eyer
Journal:  Int J Pharm X       Date:  2022-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.